ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 228155 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 228155; 2) Community: the network communities that were significantly associated with the response to NSC 228155; 3) Molecule: the relationships between components within communities and NSC 228155; 4) MDR: the compounds that were significantly associated with the NSC 228155.

NSC Compound Enrichment Correlation
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.00228818143845076 0.42095128
NSC 149286 1,4-Pentadien-3-one, 1,5-di-3-pyridyl- 0.00228818143845076 0.71563432
NSC 628114 9-N(N'-chloroethyl-N'-ethyl-1,2-diaminoethyl) 2-methoxyacridine dihydrochloride 0.00228818143845077 0.59250657
NSC 668301 Null 0.00228818143845077 0.37861173
NSC 736179 1,2-Dithiolan-3-yl-N-(3'-methoxyestra-1',3',5'(10')-triene-1 7'b-yl)pentanamide 0.00228818143845077 0.50318477
NSC 740385 7-fluoro-2-benzoyl-3-trifluoromethylquioxaline 1,4-dioxide 0.00228818143845077 0.63777743
NSC 10466 Aizen Magenta 0.00231343649986305 0.1741928
NSC 116878 Cardiac glycoside 0.00231343649986305 0.032190796
NSC 627748 Null 0.00231343649986306 0.5285233
NSC 672219 Null 0.00231343649986306 0.39177796
Total:56  Current:4    [First] [Prev] [Next] [Last]